Are you Dr. Chu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2301 Renaissance Blvd
Rn0320
King Of Prussia, PA 19406Phone+1 610-787-3490Fax+1 610-787-7043
Summary
- Dr. Myron Chu, DO is a rheumatologist in King Of Prussia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, New Jersey, and Indiana.
Education & Training
- Loma Linda University Health Education ConsortiumFellowship, Rheumatology, 1995 - 1997
- University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 1992 - 1995
- TMC Health Medical Education , Inc. (THMEP)Internship, Transitional Year, 1991 - 1992
- College of Osteopathic Medicine of the PacificClass of 1991
Certifications & Licensure
- CA State License 1995 - 2026
- PA State License 2002 - 2026
- AZ State License 1992 - 2025
- IN State License 1998 - 2025
- NJ State License 2000 - 2025
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2006
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 187 citationsA pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South KoreaFengchun Zhang, Sang Cheol Bae, Damon Bass, Myron Chu, Sally Egginton
Annals of the Rheumatic Diseases. 2018-01-02 - 30 citationsSubcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/II Study of Safety, Tolerability, Pharmacokinetics, and PharmacodynamicsRegina Kurrasch, Judith C. Brown, Myron Chu, Jenny Craigen, Philip Overend
The Journal of Rheumatology. 2013-07-01 - 8 citationsPhase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years.Fengchun Zhang, Jie Zheng, Yang Li, Guochun Wang, Mingjun Wang
RMD Open. 2022-04-01
Professional Memberships
- Member
- Fellow
- Fellow